
Hosted by Health Affairs
Each week, Health Affairs' Rob Lott brings you in-depth conversations with leading researchers and influencers shaping the big ideas in health policy and the health care industry.
298 episodes · publishes weekly · latest 2026-06-23 · ~26 min/episode
Rank
#57
Substance
85.6
/ 100
Breakdown
Scored 2026-07
Updated monthly
General rank
#5 of 267
Across the index
#57 of 6182
Substance
Top 1%
outscores 99% of the index
A Health Podyssey ranks #57 on The B2B Podcast Index with a substance score of 85.6 out of 100, scored across 5 recent episodes. It scores highest on guest caliber and specificity & evidence. Dr. Yashaswini Singh is an assistant professor and health economist with a published Health Affairs paper and demonstrated expertise in PE healthcare trends. She has clearly done substantive empirical work and understands the space deeply. However, she is not a practicing primary care operator who has directly experienced PE acquisition, nor is she a PE investor explaining strategy from the inside. She is a credible researcher but not a practitioner.
Averaged across 5 recently scored episodes, with cited evidence.
The episode delivers concrete research findings with meaningful detail: 225 PE acquisitions studied, 17% physician increase, 40% APP increase, preventive service uptake changes, and nuanced discussion of mechanisms (patient composition, workforce changes, MA coding incentives). However, it lacks deeper quantitative specifics (actual spending amounts, cost impact per patient, timeline to profitability) and relies heavily on the guest explaining her own paper rather than introducing novel external evidence or counterarguments that would deepen operator understanding.
“physicians both bill additional services as well as see additional number of patients”
“physician staff increased by about 17% after acquisitions, but APPs also increased by a much larger magnitude by 40% overall”
The paper itself appears novel in studying primary care PE acquisitions at granular level, but the podcast discussion remains within well-trodden PE healthcare frameworks: acquisition, consolidation, cost pressures, workforce expansion. The host and guest do not challenge PE assumptions rigorously or propose counterintuitive angles. The discussion of MA coding incentives and regulatory tradeoffs is thoughtful but not contrarian; it echoes existing debates about banning vs. transparency.
“PE exists partly, in large part, in response to these forces”
“we must see it as an intersection of these forces”
Dr. Yashaswini Singh is an assistant professor and health economist with a published Health Affairs paper and demonstrated expertise in PE healthcare trends. She has clearly done substantive empirical work and understands the space deeply. However, she is not a practicing primary care operator who has directly experienced PE acquisition, nor is she a PE investor explaining strategy from the inside. She is a credible researcher but not a practitioner.
“Doctor. Yashaswini Singh, a health care economist and assistant professor at Brown University”
“she has a new article in the June issue of Health Affairs describing, quote, private equity acquisitions and primary care”
Strong on study design specifics: 225 acquisitions, 2016-2022 timeframe, Medicare population, 17% physician increase, 40% APP increase, mention of specific metrics (ACC score, Medicare annual wellness visits). Weaker on operational details: no discussion of acquisition prices, actual spending deltas, practice revenue changes, or concrete examples of named practices. Regional penetration (FL 20-40%) mentioned but not explored. Missing dollar figures and timeline specifics that would help operators understand real-world impact.
“we looked at two twenty five private equity acquisitions of primary care practices during the period from 2016 to 2022”
“physician staff increased by about 17% after acquisitions, but APPs also increased by a much larger magnitude by 40%”
The host asks well-structured, open-ended questions and actively follows up (e.g., asking about the third mechanism, regulatory implications, workforce tradeoffs). However, follow-ups are soft; the host rarely challenges the guest's interpretations or introduces skeptical counterarguments. Questions like "is this about meeting demand or increasing revenue?" are fair but the guest's answer ("it's a little bit of both") is accepted without pressing on evidence or specifics. The host does not push back on the guest's tentative conclusions about lack of harm.
“And I'm curious if you have a sense of sort of the potential mechanisms that may be leading to the surge”
“is this just about sort of meeting the demand that there is versus, you know, a private equity entity finding an avenue to increase revenue?”
First period on the Index - history builds from here.
6 scored on substance · 60 tracked in total.
How ACO Conveners Are Changing the Medicare Shared Savings Program (MSSP) Behind the Scenes
2026-06-23 · 25 min
Why Medicare’s Hospital Wage Index Exceptions Jumped 60%
2026-06-16 · 23 min
Private Equity in Primary Care: Costs, Care, and Impact
2026-06-09 · 21 min
Inside CMS: How Medicare Innovation Models Are Working to Lower Costs & Scale Digital Health
2026-06-02 · 31 min
Extreme Heat’s Impact on Healthcare Use and Spending
2026-05-26 · 19 min
The Deadly Rise of Cold-Related Illness at the Intersection of Social Inequality
2026-05-19 · 20 min
Add this badge to your site - it links back here and updates automatically as you rank.
<a href="https://index.fame.so/show/a-health-podyssey" target="_blank" rel="noopener">
<img src="https://index.fame.so/badge/a-health-podyssey/badge.svg" alt="Ranked #5 on The B2B Podcast Index" width="360" height="136" />
</a>Track A Health Podyssey's rank
Get an email whenever this show moves up or down the Index. Monthly at most, no spam.
Companies, products and tools that come up most across this show's episodes.
The themes that come up most across this show's episodes.
Podcasts that dig into the same topics.